| Date | Title | Description | Source |
| 06.03.2024 | Cidara Therapeutics to Present Preclincal Data on Multiple N... | - | globenewsw... |
| 12.02.2024 | Cidara Therapeutics Receives $11.14 Million Milestone Paymen... | - | globenewsw... |
| 12.02.2024 | Cidara Therapeutics Receives $11.14 Million Milestone Paymen... | Approval triggered by positive results from ReSTORE Phase III clinical trial
Payment will advance Ci... | einpresswi... |
| 24.04.2023 | Cidara Therapeutics Receives $20 Million Milestone Payment F... | - | globenewsw... |
| 04.10.2022 | Cidara Therapeutics Receives $11.1 Million Milestone Payment... | /EIN News/ -- Milestone payment triggered by European Medicines Agency acceptance of marketing autho... | einpresswi... |
| 04.10.2022 | Cidara Therapeutics Receives $11.1 Million Milestone Payment... | Milestone payment triggered by European Medicines Agency acceptance of marketing authorization appli... | globenewsw... |
| 21.09.2022 | San Diego antifungal player nabs priority review for... | Cidara Therapeutics wants to make its mark in the world of antifungals, and thanks to the FDA,... | endpts.com... |
| 18.12.2020 | Immune Regulation makes Peter Greenleaf chairman and ... | Peter Greenleaf
→ In September, Immune Regulation raked in $53.4 million in a Series B for... | endpts.com... |
| 29.07.2019 | Genfit's elafibranor wins orphan status for primary b... | → NASH hopeful Genfit has been awarded orphan drug status by US and EU regulators for its ex... | endpts.com... |
| 21.05.2018 | CIDARA THERAPEUTICS AND RUTGERS UNIVERSITY AWARDED $5.5 MILL... | - | 5amventure... |
| 12.11.2017 | 4 newcomers to the ranks share what keeps employees motivate... | One worker calls the workplace “nirvana.” Another prizes the freedom to pursue an idea.” “I feel lik... | sandiegoun... |
| 30.03.2017 | CARB-X dishes out $48M in grants to antimicrobial startups | Launched in mid-2016, CARB-X stands for Combating Antibiotic Resistant Bacteria Biopharmaceutical Ac... | medcitynew... |
| 04.11.2016 | Cidara Therapeutics Receives $20M Credit Facility from Squar... | Cidara Therapeutics, Inc. (Nasdaq:CDTX), a San Diego, CA-based biotechnology company, entered into a... | finsmes.co... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 30.05.2016 | 5AM Ventures has raised $285M for fifth fund (Updated) | Update On Monday, it confirmed the amount in a press release on its website.
In a phone interview wi... | medcitynew... |
| 19.08.2015 | Aisling Capital launching fourth, $400M life sciences fund | A document published on the Pennsylvania Public School Employees’ Retirement System indicated the fu... | medcitynew... |
| 16.03.2015 | Cidara Therapeutics Aims for $69M With Planned IPO | Cidara Therapeutics Inc. has filed to raise up to $69 million in an IPO, the San Diego biotech discl... | sdbj.com/n... |
| 13.02.2015 | Cidara Therapeutics Completes $42M Series B |
SAN DIEGO, CA, Biotechnology company developing novel anti-infectives and immunotherapies to treat... | vcnewsdail... |
| 12.02.2015 |
Cidara Therapeutics Raises $42M
| San Diego-based Cidara Therapeutics, which is developing treatments for fungal and other infections,... | socaltech.... |
| 11.02.2015 | Antifungals and immunotherapy: Cidara Therapeutics raises $4... | Cidara won’t say who invested in this impressive Series B, just that it’s from “a syndicate of healt... | medcitynew... |
| 11.02.2015 | Cidara Therapeutics Completes $42M Series B Financing | Cidara Therapeutics, Inc., a San Diego, California-based biotechnology company developing novel anti... | finsmes.co... |
| 11.02.2015 | CIDARA THERAPEUTICS COMPLETES $42 MILLION PRIVATE SERIES B F... | - | 5amventure... |
| 11.02.2015 | Cidara Completes $42 Million Private Series B Financing | Proceeds Will Advance Novel Anti-Infectives into Clinical Studies
Cidara Therapeutics, Inc., a biot... | aislingcap... |
| 01.07.2014 | Cidara gets $32M to “rewrite the book” on dangerous fungal i... | Indeed, Stein has pivoted from the antibacterials to the antifungal space with the newly christened ... | medcitynew... |
| 30.06.2014 |
Cidara Therapeutics Gets $32M
| San Diego-based Cidara Therapeutics, a new, startup biopharmaceuticals firm working on treatments fo... | socaltech.... |
| 30.06.2014 | Cidara Therapeutics Completes $32M Series A Financing | Cidara Therapeutics, Inc., a San Diego, CA-based biopharmaceutical company, completed a $32m Series ... | finsmes.co... |
| 30.06.2014 | Cidara Therapeutics Completes $32 Million Series A Financing | Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has c... | aislingcap... |
| 30.06.2014 | Cidara Therapeutics Completes $32M Series A Financing Round | Cidara Therapeutics, a privately held bio-pharmaceutical company formerly known as K2 Therapeutics, ... | sdbj.com/n... |
| - | 5AM Ventures has raised $285M for fifth fund (Updated) | This post has been updated from an earlier version with comments from 5AM Ventures Founder and Manag... | medcitynew... |
| - | CARB-X dishes out $48M in grants to antimicrobial startups | CARB-X is making it rain.
The international antimicrobial consortium today announced grants totaling... | medcitynew... |
| - | Aisling Capital launching fourth, $400M life sciences fund | Aisling Capital, a life sciences-focused private equity firm, is raising $400 million for its fourth... | medcitynew... |
| - | Cidara gets $32M to “rewrite the book” on dangerous fungal i... | Cidara Therapeutics has emerged from relative obscurity with a new name, a new antifungal drug platf... | medcitynew... |
| - | Antifungals and immunotherapy: Cidara Therapeutics raises $4... | San Diego biotech Cidara Therapeutics just raised an impressive $42 million Series B round – with pl... | medcitynew... |
